Publications database

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

Cannabis is Europe’s most commonly used illicit drug, with around 20 million adults (15–64 years) having used it in the last year; around 3 million on a daily, or almost daily, basis...

This brochure provides an overview of the 2015 European Drug Report package and includes brief summaries of the four new additions to the Perspectives on drugs (PODs) series.

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European...

Over 80 synthetic cathinone derivatives were detected via the EU Early Warning System (EU–EWS) between 2005 and 2014. This analysis explores new worrying localised and national outbreaks of injecting these substances and...

Imported heroin has historically been available in Europe in two forms, the most common being brown heroin (its chemical base form), originating mainly in Afghanistan and other countries in south-west Asia. Less...

Synthetic drugs have been produced illicitly in Europe for over 40 years and, by global standards, Europe remains a significant producer today. Described in this analysis are current trends in illicit synthetic...

In this issue: European Drug Report 2015 highlights | Growing importance of effective treatment for cannabis use | Lisbon Addictions 2015 | European drugs summer school 2015 | First overview of the...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...